This affects both the diagnosis and management of catheter-related bloodstream infections
(CR-BSIs) because obtaining a peripheral culture may not be possible and line removal may not be feasible.
An agent-based model for evaluating surveillance methods for catheter-related bloodstream infection
Central venous catheters (CVCs) account for an estimated 90% of all catheter-related bloodstream infections
Eliminating catheter-related bloodstream infections
in the intensive care unit.
Preventing catheter-related bloodstream infection
starts with understanding the potential sources of infection.
Catheter-related bloodstream infections
(CR-BSI) occur at an average rate of 5 per 1,000 catheter days in intensive-care units in the United States (1), resulting in 80,000 episodes of CR-BSI per year (2).
The Centre for Disease Control definition of catheter-related bloodstream infection
is bacteraemia/fungaemia with an intravascular catheter, at least one positive blood culture obtained from a peripheral vein, clinical manifestations of infection and no apparent source for the bloodstream infection except the catheter.
Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection
in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension.
In prospective studies, the relative risk (RR) for a catheter-related bloodstream infection
is 2 to 855 times higher with central venous catheters than peripheral venous catheters (1-3).
Jaber (2005) discusses bacterial infections caused by catheters in patients on hemodialysis and identifies the most frequent cause of catheter-related bloodstream infection
is from the colonization of the cutaneous catheter tract with skin flora.
Misdiagnosed catheter-related bloodstream infections
can result in premature removal of vascular access, which impacts future options for new access creation (Kallen, 2013).